SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.
Document Type
Journal Article
Publication Date
1-1-2017
Journal
Current Pharmaceutical Design
Volume
23
Issue
10
DOI
10.2174/1381612823666170124123927
APA Citation
Imprialos, K., Faselis, C., Boutari, C., Stavropoulos, K., Athyros, V., Karagiannis, A., & Doumas, M. (2017). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Current Pharmaceutical Design, 23 (10). http://dx.doi.org/10.2174/1381612823666170124123927
Peer Reviewed
1
